Body Protective Compound 157 - Humira (Adalimumab) Interaction
Herbal: Body Protective Compound 157
Also Known As: BPC 157, BPC-157
Drug: Adalimumab
Brand names:
Humira
Medical Content Editor Dr. Brian Staiger, PharmD
Last updated
May 04, 2025
Interaction Details
There were no interactions found between Adalimumab and Body Protective Compound 157. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Body Protective Compound 157 Overview
BPC 157, also known as body protective compound 157 and Bepecin , is a pentadecapeptide derived from human gastric juice. It has attracted significant interest for its potential therapeutic benefits in addressing various musculoskeletal and soft tissue injuries. This peptide has been shown to expedite the healing of tendons, ligaments, and skeletal muscles in numerous preclinical studies. BPC 157 facilitates cell survival, migration, and proliferation, primarily through the activation of the FAK-paxillin pathway and upregulation of growth hormone receptors.
Research has indicated that BPC 157 can significantly enhance the outgrowth of tendon fibroblasts, improve wound closure, and stimulate reepithelialization and collagen deposition in skin injuries. Importantly, it has demonstrated effectiveness in models of both traumatic and systemic injuries, indicating a wide range of potential applications.
While promising results have been observed in rodent models, the translation of BPC 157's benefits to human clinical applications is still in the early stages.
Adalimumab Overview
-
Adalimumab injection products are used alone or with other medications to relieve the symptoms of certain autoimmune disorders (conditions in which the immune system attacks healthy parts of the body and causes pain, swelling, and damage) including the following:
-
rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) in adults,
-
juvenile idiopathic arthritis (JIA; a condition that affects children in which the body attacks its own joints, causing pain, swelling, loss of function, and delays in growth and development) in children 2 years of age and older,
-
Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) that has not improved when treated with other medications in adults and children 6 years of age and older,
-
ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) when other medications and treatments did not help or could not be tolerated in adults and children 5 years of age and older,
-
ankylosing spondylitis (a condition in which the body attacks the joints of the spine and other areas causing pain and joint damage) in adults,
-
psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin) in adults,
-
hidradenitis suppurativa (a skin disease that causes pimple-like bumps in the armpits, groin, and anal area) in adults and children 12 years of age and older,
-
uveitis (swelling and inflammation of different areas of the eye) in adults and children 2 years of age and older,
-
chronic plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in adults.
-
-
Adalimumab injection products are in a class of medications called tumor necrosis factor (TNF) inhibitors. They work by blocking the action of TNF, a substance in the body that causes inflammation.
Body Protective Compound 157 - More Interactions
Body Protective Compound 157 interacts with 0 drugs
Interaction Rating Key
These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.
| Major | The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur. |
| Moderate | Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur. |
| Minor | Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction. |
| Unknown | No interactions have been reported or no interaction data is currently available. |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.
Ask A Pharmacist About Your Herbal Questions!
Dr. Brian Staiger, PharmD
In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. He has combined his passion for pharmacy practice with the study of medical ethnobotany to improve patient care. Feel free to reach out about any of your herbal or medication questions!
Ask A Pharmacist